ExL Pharma’s 4th Proactive GCP Compliance conference, taking place April 8-10, 2013 in the Washington DC area, continues to act as the only annual forum for both senior-level clinical quality and clinical operations executives to gather, learn and discuss practical strategies to achieve and maintain global GCP compliance. This three day meeting consists of expertly presented educational sessions, case studies, panel discussions, roundtables and interactive workshops encompassing all risk-based methods for GCP compliance on both the national and international levels. The event format encourages audience participation and interaction offering an opportunity for all those in attendance to share their experiences, ask and get answers to the difficult compliance questions and engage with peers of similar responsibilities. The model for clinical research is changing, join us in April to learn how to build quality risk management approaches into your clinical operations to ensure quality research, GCP compliance and patient safety.
- Learn practical risk-based approaches to clinical quality at the only forum where both quality and operations professionals learn, discuss and engage on effective strategies to achieve and maintain global GCP compliance.
- Effectively navigate the global compliance landscape by learning from international industry and regulatory experts as they share their experience with clinical audits and inspections as well as best practices for interpreting and implementing global regulations.
- Hear case study presentations from companies of varying sizes demonstrating effective risk-based approaches for quality assessment, maintenance and management.
- Techniques for optimizing GCP education both internally and at your clinical partners to ensure compliance.
- Update on national and international GCP requirements and guidelines as well as industry presentations on how they are being interpreted and implemented.
“The conference was very well organized and very useful. I came away with a great number of additional aspects to consider and implement, and a confirmation of my belief that being proactive is the best way to go when it comes to GCP.” - Peter Langecker, CEO, Oxigene
“Exceeded expectations. Excellent conference with excellent speakers. All of us learned a lot and conferences like these are what improve the drug development process.”
- Munish Mehra, PhD, Managing Director, Global Drug Development Experts
“A fruitful conference with many very relevant topics on the agenda.”
- Lisbeth Bonefeld, Senior GCP Advisor Specialist, Novo Nordisk
Who Should Attend
Audience Profile from the over 130 Participants at the 2012 Annual Meeting
C-Level, Vice President, Director & Manager level executives from the following departments at Pharma/Biotech/Medical Device companies, CROs and other clinical trial service providers:
- Good Clinical Practice/GCP
- Clinical Quality Assurance/CQA
- Clinical Quality Control/CQC
- Clinical Operations/Management
- Audits/Inspections
- Quality Management/ Global Quality Management
- Compliance/Global Compliance
- Data Management/Systems Operations
- Clinical Monitoring
- Regulatory Affairs
- Safety & Risk Management/Operations
This conference is also relevant to clinical QA, compliance and operations professionals from:
- Quality Service Providers & Consulting Companies
- CROs
- Central, Imaging, and ECG Labs
- Investigative Sites
- IRBs
- Data Management & Software Vendors
- Safety Reporting Vendors
